Recent advancements in positron emission tomography (PET) imaging, particularly with the use of the radiopharmaceutical [68Ga]Pentixafor, have opened new avenues for assessing CXCR4 expression in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback